BCMA/CD3 Bispecific Antibody as Bridging Therapy Before CAR-T Cell Infusion in RRMM
Clinical trial NCT07407010 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07407010
- Sponsor
- Institute of Hematology & Blood Diseases Hospital, China
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-06-01
- Primary completion
- 2027-05-31
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.